PRESCRIPTION DRUG UNITARY PRICING CLAUSE WILL BE DELETED BY SENATE
PRESCRIPTION DRUG UNITARY PRICING CLAUSE WILL BE DELETED BY SENATE, Health Industry Group Purchasing Association Executive Director Robert Betz predicted at HIGPA's National Pharmacy Forum in Scottsdale, Ariz. May 24. HIGPA is a member of the Coalition of Health Care Providers Concerned About Rising Drug Costs, which has been lobbying against the provision in President Clinton's Health Security Act that would mandate equal access for pharmacy to manufacturer discounts.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth